Come up with a name for your new list and we'll add to it:
Regado Biosciences raised a round of funding on January 17, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Regado Biosciences, a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. The Company provides REG1 that is used in patients sufferin…